TEE
GRTX

Tibra Equities Europe’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Tibra Equities Europe’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-36,900
Closed -$363K – 215
2021
Q2 		$363K Buy
+36,900
New +$300K 0.11% 45

Other funds holding GRTX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tibra Equities Europe's GRTX Position: Q3 2021 in Review

Tibra Equities Europe sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q3 2021, closing a stake of 36,900 shares — an estimated $363K sold.

Tibra Equities Europe first reported a position in GRTX in Q2 2021 and held it in 1 quarter. The position peaked at $363K in Q2 2021. 40 funds tracked by Wall St. Rank hold GRTX as of Q3 2021.

  • Tibra Equities Europe reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Tibra Equities Europe sold 36,900 Galera Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $363K.
  • Tibra Equities Europe first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Tibra Equities Europe's Galera Therapeutics, Inc. Common Stock position peaked at $363K in Q2 2021.
  • 40 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Tibra Equities Europe's 13F filing for Q3 2021, filed 15 Nov 2021.